These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis. Benz PS; Fan X; Wüthrich RP Kidney Int; 1996 Jul; 50(1):156-63. PubMed ID: 8807584 [TBL] [Abstract][Full Text] [Related]
5. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261 [TBL] [Abstract][Full Text] [Related]
6. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis. Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis. Fan X; Wüthrich RP Inflammation; 1997 Feb; 21(1):105-12. PubMed ID: 9179626 [TBL] [Abstract][Full Text] [Related]
8. Enhanced hyaluronan synthesis in the MRL-Fas(lpr) kidney: role of cytokines. Feusi E; Sun L; Sibalic A; Beck-Schimmer B; Oertli B; Wüthrich RP Nephron; 1999 Sep; 83(1):66-73. PubMed ID: 10461038 [TBL] [Abstract][Full Text] [Related]
10. Cytokine gene expression in the MRL/lpr model of lupus nephritis. Lemay S; Mao C; Singh AK Kidney Int; 1996 Jul; 50(1):85-93. PubMed ID: 8807576 [TBL] [Abstract][Full Text] [Related]
11. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice. Lenda DM; Stanley ER; Kelley VR J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044 [TBL] [Abstract][Full Text] [Related]
13. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL- Wada Y; Gonzalez-Sanchez HM; Weinmann-Menke J; Iwata Y; Ajay AK; Meineck M; Kelley VR J Am Soc Nephrol; 2019 Feb; 30(2):244-259. PubMed ID: 30622154 [TBL] [Abstract][Full Text] [Related]
14. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice. Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074 [TBL] [Abstract][Full Text] [Related]
15. Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice. Menke J; Bork T; Kutska B; Byrne KT; Blanfeld M; Relle M; Kelley VR; Schwarting A Kidney Int; 2011 Feb; 79(4):452-63. PubMed ID: 20980973 [TBL] [Abstract][Full Text] [Related]
19. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells. Yao L; Chen HP; Ma Q Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470 [TBL] [Abstract][Full Text] [Related]
20. Protective role for CCR5 in murine lupus nephritis. Turner JE; Paust HJ; Bennstein SB; Bramke P; Krebs C; Steinmetz OM; Velden J; Haag F; Stahl RA; Panzer U Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1503-15. PubMed ID: 22442210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]